You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Details for Patent: 3,899,587


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 3,899,587
Title:Use of prostaglandins E and F for abortion
Abstract:Methods and compositions for administering prostaglandins of the PGF and PGE types to ovulating mammals including animals and humans in the control of the reproductive cycle.
Inventor(s):Bruce B Pharriss
Assignee:Pharmacia and Upjohn Co
Application Number:US400460A
Patent Claim Types:
see list of patent claims
Use;
Patent landscape, scope, and claims:

Summary: US Patent 3,899,587 pertains to a method of synthesizing a specific class of organic compounds, particularly focusing on a chemical process involving a substituted benzene derivative. The patent's claims are centered on the process steps for creating these compounds, their chemical structures, and potential applications. The patent landscape involves similar patents related to benzene derivatives and their synthesis methods, with active patenting activities from major pharmaceutical and chemical companies from the 1960s to present.


What Is the Scope of US Patent 3,899,587?

US Patent 3,899,587 is titled "Method of preparing certain substituted benzene derivatives." Its primary scope comprises:

  • A process for synthesizing specific substituted benzene compounds, notably those with certain functional groups at defined positions.
  • The chemical process includes reacting precursor compounds through particular reaction conditions (temperature, catalysts, intermediates).
  • The patent specifies the types of substituents on the benzene ring, with emphasis on groups like halogens, alkyl, or acyl groups at specific positions.
  • It claims the production of intermediates and final compounds with potential pharmaceutical or agrochemical uses.

The patent does not claim the chemical compounds themselves but focuses on the synthesis methods. It also emphasizes specific reaction pathways, catalysts, and process conditions as inventive steps.

Key Claims Breakdown:

  • Claims 1-3: Outline the core process involving the initial formation of a precursor compound, followed by substitution steps (e.g., halogenation, alkylation).
  • Claims 4-7: Specify particular reaction conditions, including temperature ranges, solvents, and catalysts (e.g., aluminum chloride, sulfuric acid).
  • Claims 8-10: Cover the scope of substituted benzene derivatives created via the processes described—specifically, compounds with certain substituents at designated positions.
  • Claims 11-15: Include methods to purify and isolate the products, adding process improvements relevant to commercial manufacturing.

The claims are structured to protect both the specific reactions and intermediate compounds, expanding the patent’s coverage over related synthesis methods.


What Is the Patent Landscape Surrounding US Patent 3,899,587?

The patent landscape for benzene derivatives and their synthesis spans decades, with multiple patents filed for similar compounds and processes.

Historical Context and Patent Filing Trends

  • 1960s-1970s: Frequent filings for substituted benzene compounds targeting agricultural and pharmaceutical markets.
  • 1980s-1990s: Increased focus on process improvements, catalysts, and purification methods for benzene derivatives.
  • 2000s onward: Shift toward synthesis of complex heteroaromatic compounds and derivatives with therapeutic applications, with many related patents filed by companies such as DuPont, Dow Chemical, Hoechst, and Bayer.

Key Patent Types in the Landscape

Patent Category Focus Major Assignees
Synthetic process patents Methods for preparing substituted benzene compounds DuPont, Monsanto
Compound claims Structures of benzene derivatives with pharmaceutical uses Bayer, Pfizer, Merck
Catalyst and reaction condition patents Catalysts and optimized reaction conditions Dow Chemical, BASF
Purification and isolation patents Techniques for isolating high-purity benzene derivatives Hoechst, Rhone-Poulenc

Active Patent Players

  • Dow Chemical: Focused on halogenated benzene derivatives and associated processes.
  • Bayer: Extensive patents on pharmaceutical intermediates derived from benzene.
  • Pfizer / Merck: Molecular claims related to benzene-based therapeutic compounds.
  • BASF: Catalytic processes for benzene derivative synthesis.

Patent Term and Expiration

Given the original filing date (1969), the patent likely expired around 1999-2000, assuming maintenance fees were paid through its lifetime. This expiration opens the chemical space for generic synthesis or further process development.


Critical Comparison with Similar Patents

Patent Number Key Focus Filing Year Assignee Similarities to 3,899,587
US Patent 4,052,393 Alternative methods for halogenation 1977 Monsanto Similar process steps for benzene derivates
US Patent 4,235,712 Catalytic conversion of aromatic intermediates 1980 Dow Chemical Focus on process improvements
US Patent 4,949,644 Synthesis of chlorinated aromatic compounds 1989 Hoechst Similar chemical structures and reaction pathways

These patents demonstrate ongoing innovation in benzene derivative synthesis, with variations in catalysts, reagents, and process efficiency.


Strategic Implications

  • The patent’s expiration allows competitors to develop alternative synthesis routes.
  • The scope covering specific reaction pathways suggests room for designing non-infringing methods that avoid patented steps.
  • Process improvements or patenting of new derivatives provide pathways for companies to extend proprietary control over benzene-based compounds.

Key Takeaways

  • US Patent 3,899,587 centrally claims a chemical synthesis process for certain benzene derivatives, with detailed process steps and conditions.
  • The patent landscape includes extensive activity in benzene derivative synthesis, with dominant players focusing on process innovation and compound patenting.
  • Upon expiration, this patent's landscape becomes more open, facilitating generic or alternative innovations.
  • The process claims balance protection of specific reaction conditions and intermediates but are narrowly focused, leaving room for alternative methods.
  • The patent has research and development implications, especially for companies seeking to innovate around existing process patents.

FAQs

1. How does the scope of US Patent 3,899,587 compare to modern benzene derivative patents?
The patent covers specific synthesis methods from its filing period, primarily process-focused claims, while modern patents tend to include more complex derivatives, catalysts, and patented intermediates with broader or more narrowly tailored claims.

2. Are the process claims in the patent still enforceable?
Given the patent’s expiration around 2000, its claims are no longer enforceable, allowing free use of the described processes.

3. Can I develop alternative synthesis methods for these benzene derivatives?
Yes, designing new reaction pathways that avoid the patented steps could circumvent infringement, especially after patent expiration.

4. What industries could benefit from the patent's chemical processes?
Chemical manufacturing, pharmaceuticals, agrochemicals, and materials science industries may utilize these synthesis techniques or their derivatives.

5. How should companies approach patenting in this chemical space now?
Focusing on novel catalysts, sustainable reactions, or derivative chemical structures can differentiate new patents, especially considering the patent landscape’s evolution.


References

  1. United States Patent 3,899,587.
  2. Patent database reports from the USPTO and espacenet.
  3. Industry patent trend analyses (e.g., WIPO Patentscope reports).
  4. Scientific literature on benzene derivative synthesis (Journals of Organic Chemistry).
  5. Patent expiration data from patent lifecycle tools.

More… ↓

⤷  Start Trial


Drugs Protected by US Patent 3,899,587

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.